Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (279)
- COVID-19 (163)
- Safety monitoring and information (104)
- Legislation (96)
- Compliance and enforcement (72)
- Manufacturing (57)
- Vaping hub (55)
- Labelling and packaging (38)
- Import and export (29)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (18)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 126 to 150
-
News articlesLearn about the strengthened standards for all therapeutic vaping goods for smoking cessation and nicotine dependence.
-
News articlesWe are aware of a CHOICE report where a number of sunscreens were found to not meet their claimed Sun Protection Factor (SPF) ratings.
-
Safety updatesNew warnings added of risks during anaesthesia or deep sedation.
-
Media releasesThe Therapeutic Goods Administration has commenced proceedings in the Federal Court of Australia against Philips Electronics Australia Limited (PEAL) for the alleged unlawful supply of medical devices that did not meet Australian safety and performance requirements.
-
News articlesTemporary risk-based strategies are being introduced to expedite the reduction of the Good Manufacturing Practice (GMP) Clearance Compliance Verification (CV) backlog.
-
News articlesFollowing a public consultation process , the TGA has adopted the following 19 international scientific guidelines.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
News articlesOur Good Manufacturing Practice (GMP) Clearance information resources have been updated with new information for Sponsors
-
BlogPosts from trusted people can influence what others buy. If your post is considered advertising, make sure you follow the law. Here are the key rules.
-
BlogIn many cases, pharmacists and prescribers are able to provide or prescribe another approved medicine that is on the Australian Register of Therapeutic Goods (ARTG) or they can give a different strength or dosage of the same medicine.
-
Safety updatesRisk of Guillain-Barre syndrome added to Product Information.
-
Safety updatesUpdated illustrations clarify how to use measuring syringe for oral solutions.
-
BlogTherapeutic goods can sometimes have problems. When they do, we decide if a market action is needed to fix the issue. There are four types of market actions.
-
BlogComplementary medicines are therapeutic goods that are often derived from traditional medicine practices. They can usually be purchased from supermarkets, health stores and pharmacies without seeing a doctor or pharmacist.
However, just because a medicine is available without a prescription, or claims to be ‘natural’ or ‘healthy’, doesn’t mean it’s safe for you. -
BlogWhile we encourage health practitioners to prescribe approved therapeutic goods where possible, unapproved therapeutic goods can be accessed in limited circumstances.
In making these joint decisions to use an unapproved therapeutic good, your doctor is required to inform you of the potential benefits and risks. -
News articlesUpdated information for nitrosamine impurities in medicines consistent with recent EMA updated information.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
News articlesThe dual labelling period for some medicine ingredients is ending on 30 April 2025.
-
News articlesWe are seeking applications from professionals with relevant expertise in medicine and science, and consumers with relevant expertise in consumer perspectives and issues.
-
Media releasesWe have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products.
-
News articlesWe will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Safety updatesUpdates further highlight potential risks of mood-related changes and sexual disorders.
-
Regulatory decision noticesUpdate on the progress in reducing the backlog of GMP Clearance Compliance Verification (CV) applications.